ΔΎΉΟΦ±²₯

Video

Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards

β€” New treatments reshape metastatic and muscle-invasive bladder cancer therapy

image

Latest in Video

A Potential Reason Behind COVID Vaccines' Waning Benefit

Long-lived plasma cell compartment in the bone marrow may hold the answer, says researcher

Nov 15, 2024
Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

Patients with complete response can have long treatment-free interval, study suggests

Nov 15, 2024
Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

And nearly half of responders to enfortumab vedotin plus pembrolizumab remained in remission

Nov 08, 2024
Sequencing in Advanced Urothelial Carcinoma

Navigating second-line options

Nov 01, 2024
Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

And nearly half of responders to enfortumab vedotin plus pembrolizumab remained in remission

Sequencing in Advanced Urothelial Carcinoma

Navigating second-line options

More in Video

"I'm Doing Great, So When Can I Stop My Atopic Dermatitis Treatment?"

Our panel of experts discuss when might be the right time to reduce therapy

Dec 08, 2023
image
DermGPT Looks to Improve Clinic Productivity for Dermatologists

Faranak Kamangar on how the AI tool can be used in practice to make life easier for physicians

Dec 08, 2023
image
Managing the Safety of Newer Atopic Dermatitis Treatments

Our panel of experts discuss how they monitor patients on biologics and JAK inhibitors

Dec 01, 2023
image
Biologics Offer New Options in Atopic Dermatitis

Peter Lio, MD, says he can't wait to have more flexibility for his pediatric patients

Dec 01, 2023
image
Tralokinumab Controls Moderate-to-Severe AD Over the Long Term

Steven Feldman, MD, PhD, highlights the importance of improving quality of life

Nov 27, 2023
image
How and When to Escalate Treatment for Eczema

Our panel of experts discuss the appropriate time to introduce systemic therapy or switch agents

Nov 26, 2023
image
Future of Atopic Dermatitis Management

Our understanding of eczema's potential comorbidities will likely expand, says Lakshi Aldredge

Nov 25, 2023
image
Improving Treatment Adherence in Atopic Dermatitis

We've got great treatments, says Steven Feldman, the key is getting patients to use them

Nov 20, 2023
image
The Landscape of New Treatments for Eczema

Our panel of experts discuss the "explosion" in new systemic and topical agents

Nov 17, 2023
image
Staying Up-to-Date on Approved Therapies in Atopic Dermatitis

James Del Rosso, DO, says to keep an open mind when determining the best option for patients

Nov 17, 2023
image
IL-13 Blocker for Eczema Maintains Efficacy at Less-Frequent Dosing

Will be good news for patients when drug is approved, says Emma Guttman-Yassky, MD, PhD

Nov 13, 2023
image
Transitioning Patients With Atopic Dermatitis From Topical to Systemic Therapy

Peter Lio, MD, discusses how he approaches that decision-making discussion

Nov 06, 2023
image
The Exciting Potential of Antibody-Drug Conjugates in Lung Cancer

Roy Herbst, MD, PhD, leads a discussion on ADCs targeting TROP2, HER2, and HER3

Oct 30, 2023
image
Targeting KRAS in NSCLC: Recent Progress and New Approaches

Roy Herbst, MD, PhD, leads a discussion on current and emerging treatments available

Oct 23, 2023
image
More in Video